Clinical Trial Update: Collect Clinical Data in Chinese Patients Received CUBICIN Treatment for Actual Usage in Clinical Practice

View source ↗

Summary

An observational study completed in China collected clinical data on patients treated with CUBICIN for Staphylococcus aureus bloodstream infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Bloodstream Infection

Drugs mentioned

• Cubicin (daptomycin)

Snippet

Sponsor: AstraZeneca | Conditions: S. Aureus Bloodstream Infection | Status: COMPLETED